Pacher P., Mechoulam R. Is lipid signaling through cannabinoid 2 receptors part of a protective system? (англ.) // Prog Lipid Res. : journal. — 2011. — Vol. 50, no. 2. — P. 193—211. — doi:10.1016/j.plipres.2011.01.001. — PMID21295074. — PMC3062638.
D; Latek; Kolinski, M; Ghoshdastider, U; Debinski, A; Bombolewski, R; Plazinska, A; Jozwiak, K; Filipek, S. Modeling of ligand binding to G protein coupled receptors: Cannabinoid CB1, CB2 and adrenergic β 2 AR (англ.) // Journal of Molecular Modeling : journal. — 2011. — Vol. 17, no. 9. — P. 2353—2366. — doi:10.1007/s00894-011-0986-7. — PMID21365223.
Kyrou I., Valsamakis G., Tsigos C. The endocannabinoid system as a target for the treatment of visceral obesity and metabolic syndrome (англ.) // Ann. N. Y. Acad. Sci.[англ.] : journal. — 2006. — November (vol. 1083). — P. 270—305. — doi:10.1196/annals.1367.024. — PMID17148745.
Ligresti, A.; Villano, R.; Allarà, M.; Ujváry, I. N.; Di Marzo, V. Kavalactones and the endocannabinoid system: The plant-derived yangonin is a novel CB1 receptor ligand (англ.) // Pharmacological Research[англ.] : journal. — 2012. — Vol. 66, no. 2. — P. 163—169. — doi:10.1016/j.phrs.2012.04.003. — PMID22525682.
Frost J. M., Dart M. J., Tietje K. R., Garrison T. R., Grayson G. K., Daza A. V., El-Kouhen O. F., Yao B. B., Hsieh G. C., Pai M., Zhu C. Z., Chandran P., Meyer M. D. Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB(2) cannabinoid receptor activity (англ.) // J. Med. Chem.[англ.] : journal. — 2010. — January (vol. 53, no. 1). — P. 295—315. — doi:10.1021/jm901214q. — PMID19921781.
Aung M. M., Griffin G., Huffman J. W., Wu M., Keel C., Yang B., Showalter V. M., Abood M. E., Martin B. R. Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding (англ.) // Drug Alcohol Depend : journal. — 2000. — August (vol. 60, no. 2). — P. 133—140. — doi:10.1016/S0376-8716(99)00152-0. — PMID10940540.
doi.org
Sylvaine G, Sophie M, Marchand J, Dussossoy D, Carriere D, Carayon P, Monsif B, Shire D, LE Fur G, Casellas P (1995). «Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations». Eur. J. Biochem. 232 (1): 54-61. doi:10.1111/j.1432-1033.1995.tb20780.x. PMID7556170.
Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990). «Structure of a cannabinoid receptor and functional expression of the cloned cDNA». Nature. 346 (6284): 561-4. doi:10.1038/346561a0. PMID2165569.
Munro S, Thomas KL, Abu-Shaar M (1993). «Molecular characterization of a peripheral receptor for cannabinoids». Nature. 365 (6441): 61-65. doi:10.1038/365061a0. PMID7689702.
Maurice R. Elphick (2012), "The evolution and comparative neurobiology of endocannabinoid signalling", Philosophical Transactions of the Royal Society of London B, 367(1607): 3201—3215, doi:10.1098/rstb.2011.0394, PMC3481536
Sylvaine G, Sophie M, Marchand J, Dussossoy D, Carriere D, Carayon P, Monsif B, Shire D, LE Fur G, Casellas P (1995). «Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations». Eur. J. Biochem. 232 (1): 54-61. doi:10.1111/j.1432-1033.1995.tb20780.x. PMID7556170.
Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990). «Structure of a cannabinoid receptor and functional expression of the cloned cDNA». Nature. 346 (6284): 561-4. doi:10.1038/346561a0. PMID2165569.
D; Latek; Kolinski, M; Ghoshdastider, U; Debinski, A; Bombolewski, R; Plazinska, A; Jozwiak, K; Filipek, S. Modeling of ligand binding to G protein coupled receptors: Cannabinoid CB1, CB2 and adrenergic β 2 AR (англ.) // Journal of Molecular Modeling : journal. — 2011. — Vol. 17, no. 9. — P. 2353—2366. — doi:10.1007/s00894-011-0986-7. — PMID21365223.
Munro S, Thomas KL, Abu-Shaar M (1993). «Molecular characterization of a peripheral receptor for cannabinoids». Nature. 365 (6441): 61-65. doi:10.1038/365061a0. PMID7689702.
Kyrou I., Valsamakis G., Tsigos C. The endocannabinoid system as a target for the treatment of visceral obesity and metabolic syndrome (англ.) // Ann. N. Y. Acad. Sci.[англ.] : journal. — 2006. — November (vol. 1083). — P. 270—305. — doi:10.1196/annals.1367.024. — PMID17148745.
Maurice R. Elphick (2012), "The evolution and comparative neurobiology of endocannabinoid signalling", Philosophical Transactions of the Royal Society of London B, 367(1607): 3201—3215, doi:10.1098/rstb.2011.0394, PMC3481536
Ligresti, A.; Villano, R.; Allarà, M.; Ujváry, I. N.; Di Marzo, V. Kavalactones and the endocannabinoid system: The plant-derived yangonin is a novel CB1 receptor ligand (англ.) // Pharmacological Research[англ.] : journal. — 2012. — Vol. 66, no. 2. — P. 163—169. — doi:10.1016/j.phrs.2012.04.003. — PMID22525682.
Frost J. M., Dart M. J., Tietje K. R., Garrison T. R., Grayson G. K., Daza A. V., El-Kouhen O. F., Yao B. B., Hsieh G. C., Pai M., Zhu C. Z., Chandran P., Meyer M. D. Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB(2) cannabinoid receptor activity (англ.) // J. Med. Chem.[англ.] : journal. — 2010. — January (vol. 53, no. 1). — P. 295—315. — doi:10.1021/jm901214q. — PMID19921781.
Aung M. M., Griffin G., Huffman J. W., Wu M., Keel C., Yang B., Showalter V. M., Abood M. E., Martin B. R. Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding (англ.) // Drug Alcohol Depend : journal. — 2000. — August (vol. 60, no. 2). — P. 133—140. — doi:10.1016/S0376-8716(99)00152-0. — PMID10940540.
Kyrou I., Valsamakis G., Tsigos C. The endocannabinoid system as a target for the treatment of visceral obesity and metabolic syndrome (англ.) // Ann. N. Y. Acad. Sci.[англ.] : journal. — 2006. — November (vol. 1083). — P. 270—305. — doi:10.1196/annals.1367.024. — PMID17148745.
Ligresti, A.; Villano, R.; Allarà, M.; Ujváry, I. N.; Di Marzo, V. Kavalactones and the endocannabinoid system: The plant-derived yangonin is a novel CB1 receptor ligand (англ.) // Pharmacological Research[англ.] : journal. — 2012. — Vol. 66, no. 2. — P. 163—169. — doi:10.1016/j.phrs.2012.04.003. — PMID22525682.
Frost J. M., Dart M. J., Tietje K. R., Garrison T. R., Grayson G. K., Daza A. V., El-Kouhen O. F., Yao B. B., Hsieh G. C., Pai M., Zhu C. Z., Chandran P., Meyer M. D. Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB(2) cannabinoid receptor activity (англ.) // J. Med. Chem.[англ.] : journal. — 2010. — January (vol. 53, no. 1). — P. 295—315. — doi:10.1021/jm901214q. — PMID19921781.